Loading company…
Ruilin Biomedical develops tissue and organ repair products using cell technologies and 3D-printed scaffolds.
Founded in 2021 and based in Nanjing, Ruilin Biomedical develops products for tissue and organ repair and regeneration. Its work combines multiple cell sources with 3D-printed bio-scaffold materials, with a focus on orthopaedic sports medicine and plastic surgery. The company established a 2,000-square-meter facility in Nanjing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in